Amedisys is being acquired by UnitedHealth for $3.3B, pending DOJ approval. Learn why UNH and AMED stock are impacted by ...

Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Net service ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.

Home health company Amedisys, based in Louisiana and Nashville, fell short of estimates in its third quarter earnings report.

Amedisys (AMED) delivered earnings and revenue surprises of -12.28% and 0.08%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods ...

Donald Trump will take over the presidency again in January. There will be many implications for home-based care providers, ...

UnitedHealth Group Inc. shares rose as much as 9.3% before U.S. markets opened, while shares of Humana Inc. gained as much as ...